MTX MINERALS TECHNOLOGIES INC
Industrial Inorganic Chemicals · NYSE · SEC CIK 891014 · Fiscal year ends 12/31
Financial factors as of 2026-10-04 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.8%
TTM net income YoY-4,118.8%
TTM EPS YoY-2,650.0%
Revenue 3-yr CAGR0.3%
Net income 3-yr CAGR—
Margins
Gross margin23.9%
Operating margin-1.6%
Net margin-3.1%
FCF margin5.9%
EBITDA margin—
Returns
ROE-4.1%
ROA-1.9%
ROIC (approx.)-1.2%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.61x
Current ratio1.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-3.49x
Accruals ratio-8.6%
Payout ratio—
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.07B | $2.12B | $2.17B | $2.13B | $1.86B |
| Cost of revenue | $1.55B | $1.57B | $1.66B | $1.66B | $1.41B |
| Gross profit | $518.00M | $547.70M | $507.10M | $465.00M | $446.50M |
| R&D expense | $22.90M | $23.00M | $21.20M | $20.40M | $19.50M |
| SG&A expense | $208.00M | $209.20M | $206.00M | $192.10M | $186.20M |
| Operating income | $47.40M | $286.50M | $171.80M | $214.80M | $235.70M |
| Interest expense | — | — | $59.20M | $43.90M | $37.20M |
| Pretax income | -$14.00M | $223.60M | $107.70M | $156.70M | $202.30M |
| Income tax | $4.90M | $59.40M | $23.70M | $32.10M | $36.60M |
| Net income | -$18.40M | $167.10M | $84.10M | $122.20M | $164.40M |
| EPS (basic) | -0.59 | 5.21 | 2.59 | 3.74 | 4.89 |
| EPS (diluted) | -0.59 | 5.17 | 2.58 | 3.73 | 4.86 |
| Dividends declared per share | 0.45 | 0.41 | 0.25 | 0.20 | 0.20 |
| Weighted avg. shares (diluted) | 31.40M | 32.30M | 32.60M | 32.80M | 33.80M |
| Balance sheet | |||||
| Cash & equivalents | $329.00M | $333.10M | $317.20M | $247.20M | $299.50M |
| Short-term investments | $3.60M | $4.00M | $4.30M | $5.60M | $4.90M |
| Receivables | $400.10M | $385.20M | $399.10M | $404.00M | $367.80M |
| Inventory | $350.20M | $342.10M | $325.40M | $348.80M | $297.70M |
| Current assets | $1.16B | $1.13B | $1.10B | $1.07B | $1.03B |
| PP&E, net | $1.02B | $989.70M | $986.80M | $1.05B | $1.05B |
| Goodwill | $915.90M | $913.80M | $913.60M | $914.80M | $907.50M |
| Intangibles | $208.70M | $218.10M | $231.00M | $241.90M | $251.60M |
| Total assets | $3.47B | $3.39B | $3.35B | $3.40B | $3.37B |
| Current liabilities | $555.40M | $397.70M | $457.30M | $502.60M | $419.80M |
| Short-term debt | $6.30M | $6.50M | $18.00M | $14.50M | $800,000 |
| Long-term debt | $955.00M | $959.60M | $911.10M | $928.10M | $936.20M |
| Total debt | $961.30M | $966.10M | $929.10M | $942.60M | $937.00M |
| Total liabilities | $1.72B | $1.61B | $1.66B | $1.79B | $1.79B |
| Shareholders' equity | $1.71B | $1.75B | $1.65B | $1.58B | $1.54B |
| Net debt | $632.30M | $633.00M | $611.90M | $695.40M | $637.50M |
| Shares outstanding | 31.03M | 31.90M | 32.40M | 32.50M | 33.18M |
| Cash flow statement | |||||
| Operating cash flow | $193.70M | $236.40M | $233.60M | $105.70M | $232.40M |
| Capital expenditure | $107.10M | $89.50M | $93.50M | $82.30M | $86.00M |
| Free cash flow | $86.60M | $146.90M | $140.10M | $23.40M | $146.40M |
| Investing cash flow | -$122.80M | -$94.50M | -$91.70M | -$101.60M | -$278.60M |
| Financing cash flow | -$89.30M | -$110.40M | -$71.70M | -$34.10M | $5.60M |
| Stock-based compensation | $11.90M | $11.80M | $11.30M | $10.40M | $10.70M |
| Dividends paid | $14.20M | $13.20M | $8.10M | $6.50M | $6.80M |
| Share buybacks | $58.50M | $63.60M | $14.20M | $56.00M | $74.70M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.